Blood-based mass spectrometry in plasma cell disorders: From residual secretory activity to multimodal residual disease assessment.

Published

Research record: Blood-based mass spectrometry in plasma cell disorders: From residual secretory activity to multimodal residual disease assessment.

Published in Crit Rev Oncol Hematol; first publication date 2026-11-03. PMID 42977203.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-11-03

Updated

2026-11-16

Disclaimer

professional use

Explore more